Panwar, Rakshit
McNicholas, Bairbre
Teixeira, J. Pedro
Kansal, Amit
Article History
Received: 10 June 2025
Accepted: 25 July 2025
First Online: 8 August 2025
Declarations
:
: Not applicable.
: All authors consent for the publication of this study report.
: RP, BM and AK have no competing interests to declare. JPT reports ownership interest via publicly traded stock or stock options in Eli Lilly and Company, Novo Nordisk A/S, Pfizer Inc. and research funding (provided to his institution) from La Jolla Pharmaceutical Company/Innoviva for trial related to angiotensin II use (NCT05824767).